We teamed up with senior specialist HPB dietitian, Mary Phillips, for a fourth year in a row for our annual educational event on pancreatic enzyme replacement therapy (PERT) and pancreatic cancer.
This session aimed to increase your knowledge and understanding of pancreatic exocrine insufficiency (PEI) and PERT and grow your confidence in advising patients on its effective use.
In light of the current intermittent PERT shortages across the UK, Mary also shared guidance on what to do if a patient is running low or cannot get PERT.
View the slides
Watch the session
View the agenda
- 09.00 – 09.05: Welcome and introduction
- 09.05 – 09.20: Pancreatic Exocrine Insufficiency (PEI)
- 09.20 – 10.10: Treating PEI with PERT
- 10.10 – 10.30: PERT shortage guidance
- 10.30 – 10.55: Q&A
- 10.55 – 11.00: Close
What can I expect to learn from watching this session?
By joining this educational session, you will:
- Increase your knowledge and understanding of pancreatic exocrine insufficiency (PEI) in pancreatic cancer
- Increase your ability to recognise and diagnose PEI
- Increase your knowledge and understanding of pancreatic enzyme replacement therapy (PERT)
- Be confident in advising your patients on effective use of PERT and troubleshooting issues
- How to support your patients with intermittent PERT shortages
Who is this session for?
This session is suitable for all healthcare professionals treating and supporting people with pancreatic cancer, no matter your level or role. It is particularly relevant for the following roles:
- UGI / HPB CNSs working in secondary care and specialist centres
- Dietitians working in secondary care and specialist centres
- Doctors working in secondary care and specialist centres
- Palliative care consultants and nurses
- GPs
- Support workers, patient navigators
Our speaker
Mary Phillips, Senior Specialist HPB Dietitian, Royal Surrey County Hospital NHS Foundation Trust
Mary graduated from the University of Surrey in 2000, and for the last 21 years has been working with the pancreatic surgical team at the Royal Surrey in Guildford. Her main clinical and research interest is in the management of pancreatic exocrine insufficiency and she is currently undertaking her PhD in the long-term consequences of pancreatic resection.
If you have any questions, please don’t hesitate to get in touch with us at: hpnetwork@pancreaticcancer.org.uk
